VIKAS TALREJA

[Dr Amol Akhade @SuyogCancer]

Happy That @NatureMedicine has decided to put this disclaimer secondary to voices raised on social media about the study published. Other journals can take a clue @EUplatinum

[Dr Amol Akhade @SuyogCancer]

Whats new and exciting data to look forward in ASCO GU 2026 🙂👇 @ASCO #ASCOGU26 @brunolarvol @MedwatchKate

[VIKAS TALREJA @khizmatghar]

@IITKanpur Congratulations , exceptional work and excellent human being . The whole nation is proud of her.

[IIT Kanpur @IITKanpur]

Proud Moment for IIT Kanpur

Prof. Bushra Ateeq, Professor (BSBE) and Dean of International Relations at IIT Kanpur, has been conferred with the 35th G. D. Birla Award for Scientific Research (2025) for her outstanding contributions to Biological Sciences.

Instituted by the K. K. Birla Foundation, this prestigious national award recognizes eminent Indian scientists for original and impactful research.

Prof. Ateeq’s pioneering work in cancer biology, particularly in prostate and colorectal cancers, has significantly advanced diagnostics and therapeutic strategies, reinforcing IIT Kanpur’s excellence in cutting-edge research.

Congratulations to Prof. Ateeq on this remarkable achievement!

#IITKanpur #GDBirlaAward #ScientificExcellence #WomenInScience #CancerResearch #BiologicalSciences @EduMinOfIndia @insa_academy @IndiaDST @CSIR_IND

[Dr Akhil Kapoor @drakhilkapoor1]

Our new paper in IJMPO explores how genetic clinics can transform hereditary cancer care in India & LMICs.
Early detection, family screening & personalized therapy must be made accessible & equitable.

🔗 https://t.co/an031N0Tim
#Oncology #Genetics #CancerCare

@TMC_Varanasi

[CanAssist Breast @CanAssistBreast]

The symptoms of breast cancer vary from person to person. Many do not have any symptoms at all. A few breast cancer symptoms to notice as per Dr. Vikas Talreja - Medical Oncologist, Regency Hospital, Kanpur.

To skip chemotherapy, check out https://t.co/OMGzl9gv2m
#BreastCancer

[VIKAS TALREJA @khizmatghar]

@drakhilkapoor1 Congratulations to the whole team and big win for the patients

[Dr Akhil Kapoor @drakhilkapoor1]

💊 Oral-only treatment
📈 Statistical improvement in OS (primary end point)
💸 ~$15/month
❤️ Better quality of life. @SuyogCancer @Bipinesh @Amolpatel_dr @TMC_Varanasi @oncodaily @OncBrothers @Larvol

[Dr Akhil Kapoor @drakhilkapoor1]

This is also FIRST RCT of our newly established centre @TMC_Varanasi
📈 6-month OS: 40.7% vs 26.2% (HR: 0.63; P=0.0001)
🕒 Restricted mean OS: 7.5 vs 5.4 months (P=0.036)
✅ Consistent benefit across all subgroups
🚨Immunotherapy: limited access, modest benefit for most @PMOIndia

[Dr Akhil Kapoor @drakhilkapoor1]

🚨 Just published in JCO Global Oncology 📢
Our phase III METRO-CHASE trial shows triple oral metronomic chemotherapy significantly improves survival in platinum-refractory. #HeadAndNeckCancer.
🔗 https://t.co/TpSy01t6Rb
#oncology #cancerresearch

[kothari rushabh @rushabh1388]

1/n..Under the aegis of @CRSF_IN and guidance of @DrVijayPatil11, @VanitaNoronha, Dr. Kumar sir, our long-awaited study on Triple Metronomic therapy was published in @TheCancerLetter. Please read and comment. https://t.co/ygcKwtQNiZ

[Dr Amol Akhade @SuyogCancer]

Adjuvant chemotherapy vs Adjuvant CTRT in Gall bladder cancer . Phase 3 RCT from India 🇮🇳 @aiims_newdelhi presented by Prof Dr Atul Sharma . Adjuvant chemo rt dose not add much benifit to Adjuvant chemo alone . Great discussion by @NVijayvergiaMD @ASCO #GI25 @Larvol @NiuSanford

[VIKAS TALREJA @khizmatghar]

@IndianRailMedia @indianrail @IRCTCofficial @RailwaySeva @IndianRailUsers @indianrailway__ @Eastcoastrail

[VIKAS TALREJA @khizmatghar]

@IndianRailMedia @indianrail @IRCTCofficial @RailwaySeva @IndianRailUsers @indianrailway__
What's the use of advanced rail reservation if unreserved / seat sharing is allowed in first class
Purshottam express 12802
Ndls to Puri
Coach c

[VIKAS TALREJA @khizmatghar]

@IndianRailMedia @indianrail @IRCTCofficial @RailwaySeva @IndianRailUsers @indianrailway__ @DRMKhurdaRoad @ECRlyHJP @RailwayManager

[VIKAS TALREJA @khizmatghar]

@RailMinIndia @IRCTCofficial @RailwayNorthern @RailwaySeva

[Pratik Chandrani @PratikChandrani]

Our visionary #scientist, my #mentor, a great human being @amtdutt is moving on from @CRI_ACTREC for an even greater chapter in life! Your translational cancer research will keep inspiring us for coming decades, Sir! #WeWillMissYou #NextLevel @ACTREC_TMC @TataMemorial

[Dr. Bivas Biswas @DrBivas]

Going to start a new beginning at Apollo Multispecialty Hosputal, Kolkata from 1st Jan”2024 with two of my great colleagues @DrSandipGanguly @joydeepGonco . We would like to continue our work as a hardworking, committed & passionate medical oncology team.

[Nirmal Raut @oncologician]

🤩A publication in Lancet - Treatment pattern and outcomes of leptomeningeal carcinomatosis In India https://t.co/Mcuu8sAgb3 @todrashish @DrVijayPatil11 @shrirangwar @AshayKarpe59998 @Bhosale26Bharat @SuyogCancer @VanitaNoronha @SewantiLimaye @UmutDisel @DrSteveMartin

[VIKAS TALREJA @khizmatghar]

@DrVijayPatil11 @VanitaNoronha @Nandinimenon18 @TataMemorial Congratulations